Recombinant CXCR4 gene lentivirus transfection of rat bone marrow mesenchymal stem cells in vitro

doi:10.3969/j.issn.2095-4344.2014.41.005

Abstract

Abstract:

BACKGROUND: Chemokine receptor 4 (CXCR4) is the main homing regulating factor for mesenchymal stem cells in vivo. How to improve the self-expression of CXCR4 is crucial for regulating the homing ability of stem cells in vivo targeting organs.

OBJECTIVE: To construct lentiviral vectors carrying CXCR4 or green fluorescent protein (GFP) gene, and to observe their effects on growth and secrete function of bone marrow mesenchymal stem cells.

METHODS: Lentiviral vectors were used to over-express CXCR4 in rat bone marrow mesenchymal stem cells. GFP gene was transfected as a control. Transfection efficiency was analyzed using fluorescence microscopy, RT-PCR and western blot assay for detecting the expression of CXCR4 or GFP in cells at both the mRNA and protein levels. Effects of CXCR4 expression modified on the cellular proliferation of bone marrow mesenchymal stem cells were assayed with flow cytometry. Effect of CXCR4 regulation on secretion function of bone marrow mesenchymal stem cells was determined by protein analysis from cell supernatant.

RESULTS AND CONCLUSION: CXCR4 gene or GFP gene could be transfected into bone marrow mesenchymal stem cells safely and effectively with lentivirus transfection system. Analysis of CXCR4 expression at the mRNA and protein levels confirmed the transfection efficiency. Effects of CXCR4 over-expression on the cellular proliferation of bone marrow mesenchymal stem cells and effects of CXCR4 regulation on secretion of protective factors from bone marrow mesenchymal stem cells were improved. The proliferation ability of bone marrow mesenchymal stem cells with CXCR4 over-expression was improved, which was approved with flow cytometry (P < 0.05). And it was helpful for bone marrow mesenchymal stem cells to secrete some protective factors. Many protein and soluble factors were at higher levels, and those were good at cells proliferation and immunoloregulation in bone marrow mesenchymal stem cells (P < 0.05). The method of lentiviral transfection is a safe and effective way to modify bone marrow mesenchymal stem cells. We can improve the ability of bone marrow mesenchymal stem cells in the survival and emiocytosis ability through genetic engineering.

中国组织工程研究杂志出版内容重点：干细胞；骨髓干细胞；造血干细胞；脂肪干细胞；肿瘤干细胞；胚胎干细胞；脐带脐血干细胞；干细胞诱导；干细胞分化；组织工程

全文链接：

Key words: bone marrow, mesenchymal stem cells, lentivirus, receptors, CXCR4

CLC Number:

R394.2

Cao Zhi-qiang, Wang Yang, Liu Long. Recombinant CXCR4 gene lentivirus transfection of rat bone marrow mesenchymal stem cells in vitro [J]. Chinese Journal of Tissue Engineering Research, 2014, 18(41): 6585-6590.

Figures/Tables 2

References

[1] Yamaguchi S, Kuroda S, Kobayashi H,et al.The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC)--a preliminary study using microarray analysis.Brain Res. 2006;1087(1):15-27.
[2] 宋晨阳,徐皓,陈建梅,等.静脉移植CXCR-4基因转染骨髓间充质干细胞在脊髓损伤鼠体内的迁移与分化[J].中国组织工程研究与临床康复,2011,15(23):4316-4320.
[3] 郑栋,郭军. SDF-1/CXCR4信号轴介导的骨髓间充质干细胞治疗心力衰竭的研究进展[J]. 心脏杂志,2014,26(6):730-733.
[4] 宗阿南,郑志红,史晓萍,等.探讨《关于善待实验动物的指导性意见》饲育、应用、运输及相关方面的措施[J]. 实验动物科学, 2008,25(2):63-64,67.
[5] Rankin SM.Chemokines and adult bone marrow stem cells. Immunol Lett. 2012;145(1-2):47-54.
[6] Li J, Lepadatu AM, Zhu Y,et al.Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Bioconjug Chem. 2014;25(5):907-917.
[7] Bot I, Daissormont IT, Zernecke A,et al.CXCR4 blockade induces atherosclerosis by affecting neutrophil function.J Mol Cell Cardiol. 2014;74:44-52.
[8] Wynn RF, Hart CA, Corradi-Perini C,et al.A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow.Blood. 2004;104(9):2643-2645.
[9] Liu L, Yu Q, Lin J,et al.Hypoxia-inducible factor-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood.Stem Cells Dev. 2011; 20(11):1961-1971.
[10] Maijenburg MW, van der Schoot CE, Voermans C.Mesenchymal stromal cell migration: possibilities to improve cellular therapy.Stem Cells Dev. 2012;21(1):19-29.
[11] Kean TJ, Lin P, Caplan AI, et al.MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int. 2013;2013:732742.
[12] Lau TT, Wang DA.Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine.Expert Opin Biol Ther. 2011;11(2):189-197.
[13] Xinaris C, Morigi M, Benedetti V,et al.A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion.Cell Transplant. 2013;22(3):423-436.
[14] 孙欣慰,杨铧琦,徐惠成. 17β-雌二醇通过上调CXCR4表达促进骨髓间充质干细胞的趋化迁移[J]. 第三军医大学学报,2014, 36(7):664-668.
[15] Xie J, Wang H, Song T,et al.Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4.Protoplasma. 2013;250(2):521-530.
[16] Zhao Z, Watt C, Karystinou A,et al.Directed migration of human bone marrow mesenchymal stem cells in a physiological direct current electric field.Eur Cell Mater. 2011; 22:344-358.
[17] Burks SR, Ziadloo A, Kim SJ,et al. Noninvasive pulsed focused ultrasound allows spatiotemporal control of targeted homing for multiple stem cell types in murine skeletal muscle and the magnitude of cell homing can be increased through repeated applications.Stem Cells. 2013;31(11):2551-2560.
[18] Yuan L, Sakamoto N, Song G,et al.Low-level shear stress induces human mesenchymal stem cell migration through the SDF-1/CXCR4 axis via MAPK signaling pathways.Stem Cells Dev. 2013;22(17):2384-2393.
[19] Lehwald N, Duhme C, Wildner M,et al.HGF and SDF-1-mediated mobilization of CD133+ BMSC for hepatic regeneration following extensive liver resection.Liver Int. 2014; 34(1):89-101.
[20] 刘星星,范恒,段雪云,等. SDF-1α/CXCR4轴促进间充质干细胞归巢于实验性结肠炎受损结肠[J].世界华人消化杂志,2013, 21(33):3623-3630.
[21] Bobis-Wozowicz S, Miekus K, Wybieralska E,et al.Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice.Exp Hematol. 2011;39(6):686-696.e4.
[22] Cheng Z, Ou L, Zhou X,et al.Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance.Mol Ther. 2008;16(3):571-579.
[23] Gul-Uludag H, Xu P, Marquez-Curtis LA,et al.Cationic liposome-mediated CXCR4 gene delivery into hematopoietic stem/progenitor cells: implications for clinical transplantation and gene therapy.Stem Cells Dev. 2012;21(10):1587-1596.
[24] Marquez-Curtis LA, Gul-Uludag H, Xu P,et al.CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1.Cytotherapy. 2013;15(7): 840-849.
[25] Madeira C, Mendes RD, Ribeiro SC, et al.Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy.J Biomed Biotechnol. 2010;2010: 735349.
[26] Wiehe JM, Kaya Z, Homann JM,et al.GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair.Int J Cardiol. 2013;167(5):2073-2081.
[27] Pan S, Wan JZ, Liu SS, et al. Lentivirus carrying the Atoh1 gene infects normal rat cochlea. Neural Regen Res. 2013; 8(17): 1551-1559.
[28] Dong L, Han CX,Zhang HZ, et al. Construction of a recombinant lentivirus containing human microRNA-7-3 and its inhibitory effects on glioma proliferation. Neural Regen Res. 2012;7(27): 2144-2150.
[29] Ren J, Jin P, Sabatino M,et al.Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.Cytotherapy. 2011;13(6):661-674.
[30] Cui X, Chopp M, Zacharek A,et al.Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke.Neurobiol Dis. 2009;36(1):35-41.
[31] Zeng D, Hao L, Xu W,et al.Pinch-1 was up-regulated in leukemia BMSC and its possible effect.Clin Exp Med. 2013; 13(1):21-27.
[32] 薛武军,李旭,郭奇,等. 监测肾移植术后IL-2和sIL-2R的变化及其意义[J]. 中华泌尿外科杂志,1995,16(3):148-149,190.
[33] 傅颖媛,王斌,冯练强.同种异体肾移植者与正常人NK细胞活性及IL-2R的研究[J]. 江西医学院学报,1993,33(4):16-18.
[34] 黄萱,热衣汗,孙岩,等.急性肾排斥反应时IFN-γ和IL-10的表达及意义[J]. 细胞与分子免疫学杂志,2010,26(5):484-486.
[35] 毕树雄,戴尅戎,汤亭亭. IL-4与IL-10联合诱导异种骨移植免疫耐受的实验研究[J]. 中国矫形外科杂志,2005,13(15): 1174-1178.
[36] 芮晓晖,蔡端,张群华,等. TNF-α和IL-10在非协调性异种肝移植中的作用探讨[J]. 中华肝胆外科杂志,2002,8(11):680-682.
[37] 宋艳玲,赖天宝,李嫚,等. VEGF基因修饰MSCs移植对脑梗死大鼠血管源性机制的实验研究[J]. 卒中与神经疾病,2011,18(6): 323-325,370.
[38] 王晓艳,苏又苏,谢培益,等. VEGF基因转染同种异体骨髓间充质干细胞对心肌梗死的治疗作用[J]. 中西医结合心脑血管病杂志, 2008,6(10):1177-1178.
[39] 杨宝宏,于津浦,李慧,等. 乳腺癌髓系来源抑制细胞中IDO对T淋巴细胞免疫抑制作用初探[J]. 中国肿瘤临床,2012,39(9): 506-509.
[40] 徐鹏,葛海燕. TGF-α对人脂肪来源干细胞Survivin蛋白的影响[J]. 同济大学学报:医学版,2013,34(1):17-20.
[41] Casiraghi F, Perico N, Remuzzi G.Mesenchymal stromal cells to promote solid organ transplantation tolerance.Curr Opin Organ Transplant. 2013;18(1):51-58.
[42] Rosborough BR, Raïch-Regué D, Turnquist HR,et al.Regulatory myeloid cells in transplantation.Transplantation. 2014;97(4):367-379.